Is a Graduate Degree in Bioinformatics Still Worth It?
The pay is still good, but getting into the field is tougher. Here’s what I think my students should know before making their decision.
I decided I wanted to be a university professor when I was 12, interested in basic research about how living things are connected. For me, there was never a question about whether a Ph.D. was worth it. The doctorate and postdoc were simply what I needed for the job I wanted, and I covered every step with grants I wrote myself, starting as an undergraduate.
Most of my students, however, do have to ask that question. Every semester, someone stays after class to ask whether a graduate degree is worth it. Two years ago my advice was simple: apply to five to ten jobs a week, expect four or five interviews a semester, and hope for one or two offers. That routine is no longer enough. On the career platform Handshake, the class of 2026 sent 23 applications for every full-time job, double the rate of the class of 2023.
The issue isn’t pay. The real challenge is getting into the field.
The pay is still strong
According to the U.S. Department of Education’s College Scorecard, graduates in bioinformatics and computational biology earned a median of about $62,500 one year after getting their bachelor’s degree, and $95,000 after five years. General biology graduates earned $36,600 and $64,700. For those with a master’s, the bioinformatics group earned $82,300 and $120,400, compared to $49,000 and $69,500 for biology. In the first year, bioinformatics paid about 70 percent more than biology at every degree level. Computer science paid even more than both.
A couple of cautions: These graduates finished before ChatGPT came out, so these numbers are a baseline, not a prediction. Also, the category combines bioinformatics with biostatistics.1 Another federal dataset, using state wage records, shows a smaller first-year gap for bachelor’s graduates, about 40 percent, but the trend is similar.
The door is narrower: AI
Stanford economists, looking at payroll records for millions of American workers, found no overall job loss from AI. However, employment of 22- to 25-year-olds in the most AI-exposed jobs is now 19 percent below where it would be had it kept pace with young workers in less-exposed jobs. Experienced workers don’t show this gap. The authors say this is a pattern, not proof that AI caused it. Between May 2025 and May 2026, entry-level job postings on Indeed dropped by 7.5 percent, while senior postings went up by 14.7 percent.
The study makes an important distinction. When AI mostly replaces people in doing tasks, young workers lost jobs. When AI helps people do more, their employment stayed steady. The key question is whether AI is your tool or your competition.
In my field, I mostly see AI as a tool. It can write routine code and lets one person handle much more data. But the core of the job is different: turning biological data into knowledge, testing ideas, and connecting evidence from different areas. Data from Anthropic, the company behind the Claude chatbot, partly support this. In April and May 2026, Claude automated work in 50 percent of conversations related to bioinformatics tasks, compared to 61 percent for software development. Still, the bioinformatics data are limited, and the gap has gotten smaller since 2025. My field is closer to using AI as a tool, but it’s not completely safe from being replaced.
The door is narrower: money
The Trump administration asked Congress to cut the National Institutes of Health budget by about 40 percent for 2026, but Congress refused and kept it flat. Still, the National Science Foundation made 45 percent fewer new awards in 2026 than its average from 2021 to 2024. With fewer grants, labs are hiring fewer technicians, students, and postdocs. Two people I know lost federal jobs in the 2025 cuts. One of my former students found another job, and a friend from the CDC now works in the mortgage industry, hoping to return to science.
Startups were affected too. Congress let the federal small-business research programs that support many biotech companies lapse for six months. Investors also pulled back. Globally, seed and Series A biotech deals dropped from 60 to 50 between early 2025 and early 2026, according to J.P. Morgan. In my experience, startups often give young bioinformaticians their first job.
What a Ph.D. gets you
If employers want experience, how does someone just starting out get it? In November 2026, I looked at 118 U.S. bioinformatics job ads from 51 employers, mostly biotech companies. The largest group, 40 percent, required a Ph.D. Only 10 ads explained how different degrees could substitute for experience. For example, Twist Bioscience asked for a “Ph.D. with 3+ years, Master’s degree with 6+ years, or Bachelor’s degree with 8+ years of relevant experience.” In those ten ads, a Ph.D. counted for about three years of experience, which is about half the time it takes to earn one. Of the ads that listed years for a Ph.D., only one didn’t require any. So, a doctorate doesn’t replace experience. It opens up research jobs that require it and gives you time to build a record that matters.
In 2024, among new U.S. doctorates in bioinformatics, biostatistics, and computational biology who had a job or postdoc lined up, 39 percent went into industry and 35 percent took postdocs. Across all biology, those numbers were 18 percent for industry and 65 percent for postdocs. New biology Ph.D.s expected a median salary of $120,000 in industry, which is double the $60,000 for a postdoc.
A Ph.D. is also tougher than most people think. In my experience, anyone who finishes one has usually dealt with a harder problem than they’ll face in their next job.
Three things to keep in mind. First, never pay for a research doctorate. It should come with a stipend and tuition waiver. Federal graduate loans are unsubsidized, so interest adds up while you study. Most doctorates in related fields finish without graduate debt: 80 percent in biology and 86 percent in computer science. Second, a Ph.D. doesn’t guarantee a job. About 27 percent of new bioinformatics doctorates were still job hunting at graduation. Third, the academic path is long: among new bioinformatics Ph.D.s heading into academia, postdocs outnumbered academic jobs more than two to one.
What you can do now
Learn to code well, not just the basics. In the job ads I reviewed, 81 percent mentioned Python, 67 percent mentioned machine learning, and 46 percent mentioned statistics. Learn biology deeply enough to spot when a result doesn’t make sense, since AI won’t always catch mistakes. Use AI often, but think critically about it. Build a public record: share code on GitHub, create a tool others use, write a preprint, or make a poster. If employers are hesitant to hire beginners, show them you’re not one. If you go for a Ph.D., try to get an internship, since many ads ask for industry experience. Apply broadly: five to ten applications a week is now the minimum. And look beyond pharma. One of my Ph.D. students is heading to a postdoc at a natural history museum in Stuttgart, and master’s graduates from our program work as bioinformaticians at the San Diego Zoo.
Your path doesn’t have to look like mine. Start by thinking about what you want to be doing in ten years, then pick the degree that will help you get there. The field is more competitive now, but it’s not closed. Go in prepared.
How I worked: I used Claude, an AI assistant from Anthropic, to help find and check sources and analyze federal data and job ads. Grammarly helped with editing. The arguments and any mistakes are my own.
Explore the College Scorecard data Read the Stanford study
-
The federal category CIP 26.11 groups bioinformatics, computational biology, biostatistics, and biometry. Biostatistics accounts for 8 percent of its bachelor’s degrees and 55 percent of its master’s degrees (IPEDS completions, 2020-21 and 2021-22). ↩
Previous post
Why Do We in Academic Science Go Quiet in Rooms Where the Money Is?